Pharmacotherapy of Interstitial Pneumonia and Idiopathic Pulmonary Fibrosis

dc.contributor.advisorMegyeri, Attila
dc.contributor.advisordeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.authorDai, Monami
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentDrimba, László
dc.contributor.opponentPórszász, Róbert
dc.contributor.opponentdeptKenézy Kórház Központi Aneszteziológiai és Intenzív Terápiás Osztályhu_HU
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.date.accessioned2019-01-30T10:56:43Z
dc.date.available2019-01-30T10:56:43Z
dc.date.created2018
dc.description.abstractInterstitial lung disease (ILD) is a huge group of lung disorders and these days it is getting more common than previously diagnosed. It can be categorized into three main classes: autoimmune disease associated ILD, drug induced ILD, and idiopathic ILD. For rheumatoid arthritis associated ILD, interstitial pneumonia is one of the most common complications, and three drugs (prednisone, mycophenolate mofetil, and cyclophosphamide) are used. Among idiopathic ILD, number of new cases and mortality for idiopathic pulmonary fibrosis (IPF) are rising. With the old treatment, three-drug regimen (azathioprine, prednisone, and N-acetylcysteine), rate of death and hospitalization were increased. Nowadays, with increasing recognition of fibroblast proliferation in the pathogenesis of IPF, treatment is turning towards antifibrotic agents, which are pirfenidone and nintedanib.hu_HU
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent49hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/263398
dc.language.isoenhu_HU
dc.subjectInterstitial Pneumonia Idiopathic Pulmonary Fibrosishu_HU
dc.subject.dspaceDEENK Témalista::Orvostudomány::Farmakológiahu_HU
dc.titlePharmacotherapy of Interstitial Pneumonia and Idiopathic Pulmonary Fibrosishu_HU
Fájlok